20044532

Source:http://linkedlifedata.com/resource/pubmed/id/20044532

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0006644, umls-concept:C0080093, umls-concept:C0332206, umls-concept:C0441889, umls-concept:C0597357, umls-concept:C1280500, umls-concept:C1608665
pubmed:issue	2
pubmed:dateCreated	2010-1-26
pubmed:abstractText	Although caffeinol (a combination of a low dose of caffeine and ethanol) was shown to robustly reduce stroke damage in experimental models and is now in clinical evaluation for treatment of ischemic stroke, little is known about the potential mechanism of its action.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/1R01NS040974, http://linkedlifedata.com/resource/pubmed/grant/R01 NS040974-01A1, http://linkedlifedata.com/resource/pubmed/grant/R01 NS040974-02, http://linkedlifedata.com/resource/pubmed/grant/R01 NS040974-03, http://linkedlifedata.com/resource/pubmed/grant/R01 NS040974-04, http://linkedlifedata.com/resource/pubmed/grant/R01 NS040974-04S1
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/20044532-10366195, http://linkedlifedata.com/resource/pubmed/commentcorrection/20044532-10698017, http://linkedlifedata.com/resource/pubmed/commentcorrection/20044532-12496316, http://linkedlifedata.com/resource/pubmed/commentcorrection/20044532-12728267, http://linkedlifedata.com/resource/pubmed/commentcorrection/20044532-15145766, http://linkedlifedata.com/resource/pubmed/commentcorrection/20044532-15569874, http://linkedlifedata.com/resource/pubmed/commentcorrection/20044532-15684650, http://linkedlifedata.com/resource/pubmed/commentcorrection/20044532-19251183, http://linkedlifedata.com/resource/pubmed/commentcorrection/20044532-2467382, http://linkedlifedata.com/resource/pubmed/commentcorrection/20044532-2572303, http://linkedlifedata.com/resource/pubmed/commentcorrection/20044532-7477192, http://linkedlifedata.com/resource/pubmed/commentcorrection/20044532-7526488, http://linkedlifedata.com/resource/pubmed/commentcorrection/20044532-7616394, http://linkedlifedata.com/resource/pubmed/commentcorrection/20044532-7746802, http://linkedlifedata.com/resource/pubmed/commentcorrection/20044532-8383926, http://linkedlifedata.com/resource/pubmed/commentcorrection/20044532-9346429
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0235266
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Caffeine, http://linkedlifedata.com/resource/pubmed/chemical/Dizocilpine Maleate, http://linkedlifedata.com/resource/pubmed/chemical/Drug Combinations, http://linkedlifedata.com/resource/pubmed/chemical/Ethanol, http://linkedlifedata.com/resource/pubmed/chemical/Excitatory Amino Acid Agonists, http://linkedlifedata.com/resource/pubmed/chemical/Excitatory Amino Acid Antagonists, http://linkedlifedata.com/resource/pubmed/chemical/Guanidines, http://linkedlifedata.com/resource/pubmed/chemical/N-Methylaspartate, http://linkedlifedata.com/resource/pubmed/chemical/Neuroprotective Agents, http://linkedlifedata.com/resource/pubmed/chemical/Neurotoxins, http://linkedlifedata.com/resource/pubmed/chemical/Phosphodiesterase Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, N-Methyl-D-Aspartate, http://linkedlifedata.com/resource/pubmed/chemical/aptiganel, http://linkedlifedata.com/resource/pubmed/chemical/caffeinol
pubmed:status	MEDLINE
pubmed:month	Feb
pubmed:issn	1524-4628
pubmed:author	pubmed-author:AronowskiJaroslawJ, pubmed-author:GrottaJames CJC, pubmed-author:PalusinskiRobertR, pubmed-author:PiriyawatPaisithP, pubmed-author:StrongRogerR, pubmed-author:ZhaoXiurongX
pubmed:issnType	Electronic
pubmed:volume	41
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	363-7
pubmed:dateRevised	2011-7-22
pubmed:meshHeading	pubmed-meshheading:20044532-Animals, pubmed-meshheading:20044532-Brain Ischemia, pubmed-meshheading:20044532-Caffeine, pubmed-meshheading:20044532-Disease Models, Animal, pubmed-meshheading:20044532-Dizocilpine Maleate, pubmed-meshheading:20044532-Dose-Response Relationship, Drug, pubmed-meshheading:20044532-Drug Combinations, pubmed-meshheading:20044532-Drug Synergism, pubmed-meshheading:20044532-Ethanol, pubmed-meshheading:20044532-Excitatory Amino Acid Agonists, pubmed-meshheading:20044532-Excitatory Amino Acid Antagonists, pubmed-meshheading:20044532-Guanidines, pubmed-meshheading:20044532-Male, pubmed-meshheading:20044532-N-Methylaspartate, pubmed-meshheading:20044532-Nerve Degeneration, pubmed-meshheading:20044532-Neuroprotective Agents, pubmed-meshheading:20044532-Neurotoxins, pubmed-meshheading:20044532-Phosphodiesterase Inhibitors, pubmed-meshheading:20044532-Rats, pubmed-meshheading:20044532-Rats, Inbred SHR, pubmed-meshheading:20044532-Rats, Sprague-Dawley, pubmed-meshheading:20044532-Receptors, N-Methyl-D-Aspartate, pubmed-meshheading:20044532-Time Factors, pubmed-meshheading:20044532-Treatment Outcome
pubmed:year	2010
pubmed:articleTitle	Caffeinol at the receptor level: anti-ischemic effect of N-methyl-D-aspartate receptor blockade is potentiated by caffeine.
pubmed:affiliation	Stroke Program, Department of Neurology, University of Texas Medical School at Houston, Houston, TX 77030, USA.
pubmed:publicationType	Journal Article, Research Support, N.I.H., Extramural